Arcturus Therapeutics

Arcturus Therapeutics News & Events

SEC Filings

Filing date Description Form Filing Group Issuer View

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
Arcturus Therapeutics Holdings Inc. View HTML

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

424B5
Registration Statements
Arcturus Therapeutics Holdings Inc. View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
Arcturus Therapeutics Holdings Inc. View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Arcturus Therapeutics Holdings Inc. View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
Arcturus Therapeutics Holdings Inc. View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Arcturus Therapeutics Holdings Inc. View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
Arcturus Therapeutics Holdings Inc. View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Arcturus Therapeutics Holdings Inc. View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Arcturus Therapeutics Holdings Inc. View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Arcturus Therapeutics Holdings Inc. View HTML

Copyright Morningstar